Resmed Inc (RMD) Net Margin (2009 - 2026)

Resmed (RMD) has reported Net Margin for 18 consecutive years, with 26.2% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Margin fell 197.0% year-over-year to 26.2%; the trailing twelve-month figure through Jun 2026 stood at 26.94% (down 27.0% YoY), and the FY2026 full-year result was 26.94%, down 27.0% from the prior year.
• Net Margin slipped to 26.2% in Q2 2026 per RMD's latest filing, from 27.86% in the prior quarter.
• Across five years, Net Margin topped out at 28.26% in Q1 2025 and bottomed at 17.96% in Q4 2023.
• Historically, Net Margin has averaged 23.92% across 5 years, with a median of 24.5% in 2024.
• The sharpest annual moves came in 2022 and 2023: Net Margin surged 3092 bps in 2022, then plunged 380 bps in 2023.
• Over 5 years, Net Margin stood at 21.76% in 2022, then fell by 17 bps to 17.96% in 2023, then surged by 50 bps to 26.88% in 2024, then rose by 3 bps to 27.59% in 2025, then dropped by 5 bps to 26.2% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 26.2%, 27.86%, and 27.59% for Q2 2026, Q1 2026, and Q4 2025 respectively.